Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
novartis
zolgensma
3
×
amgen
avexis
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
centers for disease control and prevention
clinical trials
detroit blog main
detroit top stories
fda
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
martin shkreli
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
3b pharmaceuticals
What
biotech
3
×
news
roundup
according
akcea
august
bio
busy
cases
centers
cigarettes
control
days
deaths
decisions
devices
disease
driving
drug
drugs
electronic
fda
good
healthcare
history
improved
including
industry
injuries
innovation
innovations
investment
legacy
life
linked
long
lung
medical
nash
nods
Language
unset
Current search:
zolgensma
×
biotech
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
